JP2022513111A5 - - Google Patents
Info
- Publication number
- JP2022513111A5 JP2022513111A5 JP2021528936A JP2021528936A JP2022513111A5 JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5 JP 2021528936 A JP2021528936 A JP 2021528936A JP 2021528936 A JP2021528936 A JP 2021528936A JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna
- sequence
- group
- ids
- sequence ids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306562.2 | 2018-11-23 | ||
| EP18306562 | 2018-11-23 | ||
| PCT/EP2019/082216 WO2020104649A2 (en) | 2018-11-23 | 2019-11-22 | Novel rna compositions and methods for inhibiting angptl8 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513111A JP2022513111A (ja) | 2022-02-07 |
| JP2022513111A5 true JP2022513111A5 (https=) | 2022-11-29 |
| JP7707065B2 JP7707065B2 (ja) | 2025-07-14 |
Family
ID=64564803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021528936A Active JP7707065B2 (ja) | 2018-11-23 | 2019-11-22 | Ａｎｇｐｔｌ８を阻害するための新規のｒｎａ組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12416004B2 (https=) |
| EP (1) | EP3884051A2 (https=) |
| JP (1) | JP7707065B2 (https=) |
| CN (1) | CN113166760A (https=) |
| WO (1) | WO2020104649A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166760A (zh) | 2018-11-23 | 2021-07-23 | 赛诺菲 | 用于抑制angptl8的新型rna组合物和方法 |
| CN114728999A (zh) * | 2019-09-05 | 2022-07-08 | 赛诺菲 | 含有核苷酸类似物的寡核苷酸 |
| EP4359530A1 (en) * | 2021-06-24 | 2024-05-01 | Eli Lilly and Company | Novel rna therapeutics and uses thereof |
| CN120457209A (zh) | 2022-12-23 | 2025-08-08 | 伊莱利利公司 | 新型rna治疗剂及其用途 |
| WO2024160147A1 (zh) * | 2023-02-01 | 2024-08-08 | 北京福元医药股份有限公司 | 抑制血管生成素样蛋白8基因表达的siRNA、其缀合物和药物组合物及用途 |
| WO2024227059A2 (en) * | 2023-04-27 | 2024-10-31 | Aligos Therapeutics, Inc. | Short interfering nucleic acid (sina) molecules targeting angptl 3 and angptl 8 and methods of using the same |
| WO2025264952A2 (en) | 2024-06-21 | 2025-12-26 | Eli Lilly And Company | Novel rna therapeutics and uses thereof |
| CN119367545B (zh) * | 2025-01-02 | 2025-04-08 | 山东第一医科大学(山东省医学科学院) | 靶向干预ANGPTL8 mRNA在制备治疗高同型半胱氨酸血症药物中的应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5665710A (en) | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| EP0786522A2 (en) | 1992-07-17 | 1997-07-30 | Ribozyme Pharmaceuticals, Inc. | Enzymatic RNA molecules for treatment of stenotic conditions |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6054299A (en) | 1994-04-29 | 2000-04-25 | Conrad; Charles A. | Stem-loop cloning vector and method |
| US5976567A (en) | 1995-06-07 | 1999-11-02 | Inex Pharmaceuticals Corp. | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| US7422902B1 (en) | 1995-06-07 | 2008-09-09 | The University Of British Columbia | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| US5981501A (en) | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
| AU747597B2 (en) | 1998-07-20 | 2002-05-16 | Inex Pharmaceuticals Corporation | Liposomal encapsulated nucleic acid-complexes |
| MXPA01003643A (es) | 1998-10-09 | 2003-07-21 | Ingene Inc | Produccion de adnss in vivo. |
| JP2002527061A (ja) | 1998-10-09 | 2002-08-27 | インジーン・インコーポレイテッド | ｓｓＤＮＡの酵素的合成 |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| EP2020988B1 (en) | 2006-04-28 | 2017-08-16 | Children's Hospital Medical Center | Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| CN101500548A (zh) * | 2006-08-18 | 2009-08-05 | 弗·哈夫曼-拉罗切有限公司 | 用于体内递送多核苷酸的多缀合物 |
| EP2316943B1 (en) | 2007-07-05 | 2013-06-19 | Novartis AG | DSRNA for treating viral infection |
| WO2009073809A2 (en) | 2007-12-04 | 2009-06-11 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| US20100249214A1 (en) | 2009-02-11 | 2010-09-30 | Dicerna Pharmaceuticals | Multiplex dicer substrate rna interference molecules having joining sequences |
| AU2013299717B2 (en) * | 2012-08-06 | 2018-06-28 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugated RNA agents and process for their preparation |
| DK2992098T3 (da) | 2013-05-01 | 2019-06-17 | Ionis Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression |
| RS62769B1 (sr) | 2016-04-08 | 2022-01-31 | Regeneron Pharma | Postupci za lečenje hiperlipidemije inhibitorom angptl8 i inhibitorom angptl3 |
| US11897911B2 (en) | 2018-03-07 | 2024-02-13 | Sanofi | Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same |
| CN113166760A (zh) | 2018-11-23 | 2021-07-23 | 赛诺菲 | 用于抑制angptl8的新型rna组合物和方法 |
| CN115176011B (zh) | 2019-08-27 | 2025-11-11 | 赛诺菲 | 用于抑制pcsk9的组合物和方法 |
| CN114728999A (zh) | 2019-09-05 | 2022-07-08 | 赛诺菲 | 含有核苷酸类似物的寡核苷酸 |
| WO2022079222A1 (en) | 2020-10-16 | 2022-04-21 | Sanofi | Novel rna compositions and methods for inhibiting angptl3 |
| WO2022079221A1 (en) | 2020-10-16 | 2022-04-21 | Sanofi | Rna compositions and methods for inhibiting lipoprotein(a) |
| EP4232455A2 (en) | 2020-10-20 | 2023-08-30 | Sanofi | Novel ligands for asialoglycoprotein receptor |
-
2019
- 2019-11-22 CN CN201980077074.6A patent/CN113166760A/zh active Pending
- 2019-11-22 JP JP2021528936A patent/JP7707065B2/ja active Active
- 2019-11-22 EP EP19805337.3A patent/EP3884051A2/en active Pending
- 2019-11-22 US US17/296,530 patent/US12416004B2/en active Active
- 2019-11-22 WO PCT/EP2019/082216 patent/WO2020104649A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513111A5 (https=) | ||
| JP2022546040A5 (https=) | ||
| JP2022547888A5 (https=) | ||
| JP2019530656A5 (https=) | ||
| TWI680767B (zh) | 用於增強的細胞攝取之化合物及方法 | |
| JP2022106928A (ja) | 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用 | |
| HRP20200672T1 (hr) | RNAi SREDSTVA, PRIPRAVCI I POSTUPCI NJIHOVE UPOTREBE ZA LIJEČENJE BOLESTI POVEZANIH S TRANSTIRETINOM (TTZ) | |
| ES2753174T3 (es) | Métodos de tratamiento de Síndrome de Alport | |
| JP2021517126A5 (https=) | ||
| JP2021533804A5 (https=) | ||
| ES2562658T3 (es) | Procedimientos y medios para el salto eficiente del exón 45 en el pre-ARNm de la distrofia muscular de Duchenne | |
| JP2017532038A5 (https=) | ||
| JP2017525705A5 (https=) | ||
| FI4426270T3 (fi) | Lipidi-nanopartikkelit oligonukleotidien kuljetusta varten | |
| IL316808A (en) | Modified double-stranded RNA materials and their uses | |
| AU2017202883A1 (en) | Boronic acid conjugates of oligonucleotide analogues | |
| JP2022534702A5 (https=) | ||
| RU2020135289A (ru) | Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в | |
| JP2010528041A5 (https=) | ||
| RU2011127079A (ru) | Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с | |
| CA3057561A1 (en) | Rna interference mediated inhibition of tmprss6 | |
| CN103492569A (zh) | 碱基经修饰的寡核苷酸 | |
| RU2020115761A (ru) | МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В | |
| JP2022533419A5 (https=) | ||
| JP2024530956A5 (https=) |